Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma

BACKGROUND: Lung cancer is responsible of 12.4% and 17.6% of all newly diagnosed cancer cases and mortality due to cancer, respectively, and 5-year survival rate despite all improved treatment options is 15%. This survival rate reaches 66% in the Stage 1 and surgically treated patients. Early diagno...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Ağababaoğlu, İsmail, Önen, Ahmet, Demir, Ayşe Banu, Aktaş, Safiye, Altun, Zekiye, Ersöz, Hasan, Şanlı, Aydın, Özdemir, Nezih, Akkoçlu, Atila
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2017
Gaiak:
5700
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312986/
https://ncbi.nlm.nih.gov/pubmed/28178129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005903
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak